Putting organs into the deep freeze, a scavenger hunt for robots, and a book on race and reproduction
By Sarah Crespi, Angela Saini, Warren Cornwall,
Science Magazine
| 06. 29. 2023
Podcast featuring an interview with Dorothy Roberts by Angela Saini
First up this week on the show, scientists are learning how to “cryopreserve” tissues—from donor kidneys to coral larvae. Contributing Correspondent Warren Cornwall joins host Sarah Crespi to talk about the latest in freezing and thawing technology.
Next up: How much does a robot need to “know” about the world to navigate it? Theophile Gervet, a Ph.D. student at Carnegie Mellon University, discusses a scavenger hunt–style experiment that involves bringing robots to Airbnb rentals.
Finally, as part of our series of books on sex, gender, and science, host Angela Saini interviews author Dorothy Roberts, a professor of law and sociology at the University of Pennsylvania, about her book Killing the Black Body: Race, Reproduction, and the Meaning of Liberty.
[note: interview with Dorothy Roberts begins at 0:27:11.2]
TRANSCRIPT
[music]
0:00:05.7 Sarah Crespi: This is the Science Podcast for June 30th, 2023. I'm Sarah Crespi. First up this week, scientists are learning how to cryopreserve tissues from donor kidneys to coral larvae. Contributing correspondent Warren Cornwall joins me to talk about the latest in freezing...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...